Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: Twist | Rare Historical Photos

Practice Caution with This Hot Stock Up 493% in the Past Year

Twist Bioscience (TWST) has surged 493% over 52 weeks, maintaining strong technical momentum. Shares just hit a new all-time high and has a 100% “Buy” technical opinion. However, its RSI of 72.95 and high short interest signal potential overextension. Consensus price targets are well below current levels, suggesting limited upside....

Barchart · Sep 21

Twist Bioscience Eyes Profit Turnaround In 2026 After Narrowing Losses

Twist Bioscience Corporation (NASDAQ:TWST) on Friday posted mixed fourth-quarter results, reporting a loss of 45 cents per share, slightly wider than the consensus estimate of a 43-cent loss.

Benzinga · Nov 14, 2025

Twist Bioscience Turns The Tide: Q3 Sales Jump, Beats Earnings

What if a biotech company could flip its financial narrative from loss to profit in just a year? Twist Bioscience Corporation (NASDAQ:TWST) has done just that, reporting a surprising third-quarter income that defied analysts’ expectations

Benzinga · Aug 4, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

Britain's Got Talent legend praises Bruno for 'spicing up' show after Walliams exit

Britain's Got Talent star Glen Murphy of Twist and Pulse has praised new judge Bruno Tonioli for adding an extra bit of spice after he stepped in for David Walliams

Daily Mirror · May 30, 2023

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary

Avalo Therapeutics (NASDAQ:AVTX) has dosed the first patient in the pivotal LADDER trial to assess the efficacy and safety of AVTX-803 in Subjects with Leukocyte Adhesion Deficiency Type II (LAD II) ER). Avalo shares traded in a range of $3.5 to $3.91 on a day volume of 33.54 thousand shares,…

Benzinga · Aug 2, 2022

Twist Bioscience, Astellas Join Forces To Develop Cancer Targeting Antibodies

Twist Bioscience Corporation (NASDAQ:TWST) has entered into a research collaboration and exclusive option license agreement with Astellas Pharma Inc (OTC:ALPMF) to conduct research activities to identify and optimize proprietary Twist antagonist antibodies. The antibodies will target an undisclosed checkpoint inhibitor pathway in the tumor microenvironment as potential therapeutic development candidates. Ligands in this pathway are…

Benzinga · May 9, 2022

Twist Bioscience Inks Antibody Discovery Pact With MediSix Therapeutics

Twist Bioscience Corporation (NASDAQ: TWST) and MediSix Therapeutics have collaborated to discover novel antibodies

Benzinga · Apr 7, 2022

Read news from The Economist, FT, and more,
with one subscription

Twist Bioscience Launches Synthetic RNA Positive Controls For SARS-CoV-2 Encapsulated Minicapsules

Twist Bioscience Corporation (NASDAQ: TWST) has

Benzinga · Mar 21, 2022

Twist Bioscience Raises $250M Via Equity Issued At 11% Discount

Twist Bioscience Corporation (NASDAQ: TWST) has priced its upsized underwritten public offering of

Benzinga · Feb 11, 2022

Twist Bioscience Clocks ~50% Jump In Q1 Sales, Lifts FY22 Revenue Guidance

Twist Bioscience Corp (NASDAQ: TWST) reported a

Benzinga · Feb 4, 2022

Dance Duo Twist & Pulse announce new McVitie’s and Britain’s Got Talent partnership

Twist and Pulse, aka Ashley Glazebrook and Glen Murphy, handed out McVitie’s treats and cups of tea to warm up the crowd

Wales Online · Jan 19, 2022

Coverage From

People

Bruno Tonioli

511 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

National Institutes of Health

Tonix Pharmaceuticals

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.